ArticleRegenerative therapy2016

Experience of contamination during autologous cell manufacturing in cell processing facility under the Japanese Medical Practitioners Act and the Medical Care Act.

Manabu Mizutani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.